|
Diabetes Care, Vol 21, Issue 3 403-408, Copyright © 1998 by American Diabetes Association
Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance
PM Catalano, NM Drago and SB Amini
Department of Reproductive Biology, Case Western Reserve University, MetroHealth Medical Center, Cleveland, OH 44109, USA. pcatalano@metrohealth.org
OBJECTIVE: To evaluate basal pancreatic beta-cell secretion and suppression
during infused insulin and the metabolic clearance rate of insulin in women
with normal and abnormal glucose tolerance prior to conception and during
pregnancy. RESEARCH DESIGN AND METHODS: Seven women with normal glucose
tolerance and nine women with abnormal glucose tolerance during gestation
were evaluated prior to conception, in early (12-14 weeks) and late (34-36
weeks) gestation. Basal insulin and C-peptide were measured after an 11-h
fast and during the last 40 min of a 2-h hyperinsulinemic-euglycemic clamp
at 40 mU.m-2.m-1. Suppression of basal C-peptide was calculated as the
steady-state C-peptide/basal C-peptide. The metabolic clearance rate of
insulin was calculated by dividing the insulin infusion rate by the
steady-state insulin concentration, which was corrected for residual
beta-cell secretion. RESULTS: No significant differences were noted in the
following parameters between women with normal and abnormal glucose
tolerance with advancing gestation: increase in basal insulin (P = 0.20)
and C-peptide (P = 0.12), ability of infused insulin to decrease basal
C-peptide concentration (P = 0.22), and metabolic clearance rate of insulin
(P = 0.76). There was a significant 65% increase in both basal insulin (P =
0.0005) and C-peptide (P = 0.0002) concentrations in all subjects with
advancing gestation. There was a significant (P = 0.0001) decrease in the
ability of the infused insulin to decrease basal C-peptide concentration.
C-peptide as a percentage of the basal was 64% before conception, 74% in
early pregnancy, and 108% in late pregnancy. The metabolic clearance rate
of insulin significantly (P = 0.0005) increased with advancing gestation:
pregravid 442 ml.m-2.min-1, early pregnancy 514 ml.m-2. min-1, and 526
ml.m-2.min-1 in late pregnancy. CONCLUSIONS: Pregnancy is accompanied by
progressive alterations in insulin kinetics, which are partly responsible
for the hyperinsulinemia of this condition. These alterations are more
likely a homeostatic response to the increased physiological insulin
resistance of pregnancy.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. C. Connolly, T. Papa, M. S. Smith, D. B. Lacy, P. E. Williams, and M. C. Moore
Hepatic and muscle insulin action during late pregnancy in the dog
Am J Physiol Regulatory Integrative Comp Physiol,
January 1, 2007;
292(1):
R447 - R452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Canniff, M. S. Smith, D. B. Lacy, P. E. Williams, and M. C. Moore
Glucagon secretion and autonomic signaling during hypoglycemia in late pregnancy
Am J Physiol Regulatory Integrative Comp Physiol,
September 1, 2006;
291(3):
R788 - R795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Leipold, M. Knoefler, C. Gruber, A. Huber, P. Haslinger, and C. Worda
Peroxisome Proliferator-Activated REceptor {gamma} Coactivator-1{alpha} Gene Variations Are Not Associated With Gestational Diabetes Mellitus
Reproductive Sciences,
February 1, 2006;
13(2):
104 - 107.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Connolly, L. N. Aglione, M. S. Smith, D. B. Lacy, and M. C. Moore
Pregnancy impairs the counterregulatory response to insulin-induced hypoglycemia in the dog
Am J Physiol Endocrinol Metab,
September 1, 2004;
287(3):
E480 - E488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Wu, M. Bidlingmaier, S. C. Friess, S. E. Kirk, P. Buchinger, B. Schiessl, and C. J. Strasburger
A New Nonisotopic, Highly Sensitive Assay for the Measurement of Human Placental Growth Hormone: Development and Clinical Implications
J. Clin. Endocrinol. Metab.,
February 1, 2003;
88(2):
804 - 811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Catalano
The Diabetogenic State of Maternal Metabolism in Pregnancy
NeoReviews,
September 1, 2002;
3(9):
e165 - 172.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Homko, E. Sivan, X. Chen, E. A. Reece, and G. Boden
Insulin Secretion during and after Pregnancy in Patients with Gestational Diabetes Mellitus
J. Clin. Endocrinol. Metab.,
February 1, 2001;
86(2):
568 - 573.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1998 by the American Diabetes Association.
|
|
| |
|